KYMR - Kymera Therapeutics, Inc.
83.52
-2.590 -3.101%
Share volume: 1,044,442
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$86.11
-2.59
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-07-2024 | 10-31-2024 | 02-27-2025 | 05-09-2025 | 11-04-2025 | 02-26-2026 | |
| Cash flow financing | 353.756 M | 1.412 M | 250.918 M | 2.765 M | 258.000 K | 39.510 M | 705.219 M | |
| Other financing cash flows | 48.740 M | 0.000 | 1.134 M | 548.763 M | 0.000 | 272.671 M | 573.000 K | |
| Cash flow | -16.442 M | -25.882 M | 43.048 M | 9.549 M | -30.277 M | -222.899 M | 244.074 M | |
| Net income | -48.557 M | -42.062 M | -62.487 M | -70.752 M | -65.581 M | -82.175 M | -86.981 M | |
| Depreciation | 1.461 M | 1.938 M | 1.987 M | 1.987 M | 2.048 M | 2.149 M | 2.032 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -330.607 M | 15.642 M | -157.680 M | 68.568 M | 48.615 M | -235.299 M | -394.398 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 7.402 M | 4.689 M | -189.000 K | 936.000 K | 467.000 K | 181.000 K | 106.000 K | |
| Cash Change | -16.442 M | -25.882 M | 43.048 M | 9.549 M | -30.277 M | -222.899 M | 244.074 M |